Dr. Voskuhl is the Director of the UCLA MS Program, holds the Jack H. Skirball Chair in MS, and is a Professor in the UCLA Dept. of Neurology. She has received national and international awards for her research and has continuous funding for over 20 years. Professor Voskuhl uses a "Bedside to Bench to Bedside" approach, basing reserach on clinical observations, understanding them in the lab, then designing novel clincal trials. She sees MS patients in the neurology clinic and mentors at the postdoctoral, graduate, and undergradate levels.
Voskuhl Rhonda R, Wang HeJing, Wu T C Jackson, Sicotte Nancy L, Nakamura Kunio, Kurth Florian, Itoh Noriko, Bardens Jenny, Bernard Jacqueline T, Corboy John R, Cross Anne H, Dhib-Jalbut Suhayl, Ford Corey C, Frohman Elliot M, Giesser Barbara, Jacobs Dina, Kasper Lloyd H, Lynch Sharon, Parry Gareth, Racke Michael K, Reder Anthony T, Rose John, Wingerchuk Dean M, MacKenzie-Graham Allan J, Arnold Douglas L, Tseng Chi Hong, Elashoff Robert Estriol combined with glatiramer acetate for women with relapsing-remitting multiple sclerosis: a randomised, placebo-controlled, phase 2 trial The Lancet. Neurology, 2016; 15(1): 35-46.
Voskuhl Rhonda Preclinical studies of sex differences: a clinical perspective Biology of sex differences, 2016; 7: 7.
Itoh Noriko, Itoh Yuichiro, Tassoni Alessia, Ren Emily, Kaito Max, Ohno Ai, Ao Yan, Farkhondeh Vista, Johnsonbaugh Hadley, Burda Josh, Sofroniew Michael V, Voskuhl Rhonda R Cell-specific and region-specific transcriptomics in the multiple sclerosis model: Focus on astrocytes Proceedings of the National Academy of Sciences of the United States of America, 2018; 115(2): E302-E309.
Kim Roy Y, Mangu Darian, Hoffman Alexandria S, Kovash Rojan, Jung Eunice, Itoh Noriko, Voskuhl Rhonda Oestrogen receptor β ligand acts on CD11c+ cells to mediate protection in experimental autoimmune encephalomyelitis Brain : a journal of neurology, 2018; 141(1): 132-147.
Voskuhl Rhonda R, Sawalha Amr H, Itoh Yuichiro Sex chromosome contributions to sex differences in multiple sclerosis susceptibility and progression Multiple sclerosis (Houndmills, Basingstoke, England), 2018; 24(1): 22-31.
Voskuhl Rhonda, Momtazee Callene Pregnancy: Effect on Multiple Sclerosis, Treatment Considerations, and Breastfeeding Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics, 2017; 14(4): 974-984.
Itoh Yuichiro, Voskuhl Rhonda R Cell specificity dictates similarities in gene expression in multiple sclerosis, Parkinson's disease, and Alzheimer's disease PloS one, 2017; 12(7): e0181349.
Klein Robyn S, Voskuhl Rhonda, Segal Benjamin M, Dittel Bonnie N, Lane Thomas E, Bethea John R, Carson Monica J, Colton Carol, Rosi Susanna, Anderson Aileen, Piccio Laura, Goverman Joan M, Benveniste Etty N, Brown Melissa A, Tiwari-Woodruff Seema Kaushalya, Harris Tajie H, Cross Anne H Speaking out about gender imbalance in invited speakers improves diversity Nature immunology, 2017; 18(5): 475-478.
Itoh Noriko, Kim Roy, Peng Mavis, DiFilippo Emma, Johnsonbaugh Hadley, MacKenzie-Graham Allan, Voskuhl Rhonda R Bedside to bench to bedside research: Estrogen receptor beta ligand as a candidate neuroprotective treatment for multiple sclerosis Journal of neuroimmunology, 2017; 304(5): 63-71.
Golden Lisa C, Voskuhl Rhonda The importance of studying sex differences in disease: The example of multiple sclerosis Journal of neuroscience research, 2017; 95(1-2): 633-643.
Gold Stefan M, Voskuhl Rhonda R Pregnancy and multiple sclerosis: from molecular mechanisms to clinical application Seminars in immunopathology, 2016; 38(6): 709-718.
Voskuhl Rhonda, Patti Francesco Hormone replacement in menopausal women with multiple sclerosis: Looking back, thinking forward Neurology, 2016; 87(14): 1430-1431.
MacKenzie-Graham Allan, Kurth Florian, Itoh Yuichiro, Wang He-Jing, Montag Michael J, Elashoff Robert, Voskuhl Rhonda R Disability-Specific Atlases of Gray Matter Loss in Relapsing-Remitting Multiple Sclerosis JAMA neurology, 2016; 73(8): 944-53.
Voskuhl Rhonda Rebound Relapses After Ceasing Another Disease-Modifying Treatment in Patients With Multiple Sclerosis: Are There Lessons to Be Learned? JAMA neurology, 2016; 73(7): 775-6.
Voskuhl Rhonda, Wang HeJing, Elashoff Robert M Why use sex hormones in relapsing-remitting multiple sclerosis? - Authors' reply The Lancet. Neurology, 2016; 15(8): 790-791.
Voskuhl Rhonda It is time to conduct phase 3 clinical trials of sex hormones in MS - Yes Multiple sclerosis (Houndmills, Basingstoke, England), 2018; 24(11): 1413-1415.
MacKenzie-Graham Allan, Brook Jenny, Kurth Florian, Itoh Yuichiro, Meyer Cassandra, Montag Michael J, Wang He-Jing, Elashoff Robert, Voskuhl Rhonda R Estriol-mediated neuroprotection in multiple sclerosis localized by voxel-based morphometry Brain and behavior, 2018; 8(9): e01086.
Does this profile need updating? Contact Us